-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 SwZjS3cbzDM9VuXI7LvNjGy6CuvynS0eeL/06fXzgQZ+pu/zyt3bIMdbCpGJEO7h
 ijo4ZXg20MhgxGPhTIWtEg==

<SEC-DOCUMENT>0000950123-10-057889.txt : 20100614
<SEC-HEADER>0000950123-10-057889.hdr.sgml : 20100614
<ACCEPTANCE-DATETIME>20100614144039
ACCESSION NUMBER:		0000950123-10-057889
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20100608
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20100614
DATE AS OF CHANGE:		20100614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOGENEX PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-80623
		FILM NUMBER:		10894542

	BUSINESS ADDRESS:	
		STREET 1:		1522 217TH PLACE S.E.
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		4254879500

	MAIL ADDRESS:	
		STREET 1:		1522 217TH PLACE S.E.
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c02409e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="margin-left: 0.25in; width: 7.2in;font-family: 'Times New Roman',Times,serif">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>

<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 OR 15(d) of The Securities Exchange Act of 1934</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported): June 8, 2010</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>ONCOGENEX PHARMACEUTICALS, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
<TD width="32%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="32%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="32%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
<TD nowrap align="center" valign="top"><B>Delaware
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>033-80623
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>95-4343413</B></TD>
</TR>
<TR style="font-size: 1px">
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align="center" valign="top">(State or other jurisdiction<BR>
of incorporation)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(Commission File Number)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(IRS Employer Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
<TD width="48%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
<TD align="center" valign="top"><B>1522 217th Place S.E.<BR>
Bothell, Washington
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>&nbsp;<BR>98021</B></TD>
</TR>
<TR style="font-size: 1px">
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align="center" valign="top">(Address of principal executive offices)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s telephone number, including area code: <B>(425) 686-1500</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B></B></DIV>

<DIV align="center" style="font-size: 10pt"><FONT style="border-top: 1px solid #000000">(Former name or former address, if changed since last report.)</FONT></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio --> </DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
&nbsp;

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">At the 2010 Annual Meeting of Stockholders (the &#147;2010 Annual Meeting&#148;) of OncoGenex
Pharmaceuticals, Inc. (the &#147;Company&#148;) held on June&nbsp;8, 2010, stockholders of the Company approved
the 2010 Performance Incentive Plan (the &#147;2010 Plan&#148;). A summary of the material terms of the 2010
Plan is set forth in the Company&#146;s definitive proxy statement filed with the Securities and
Exchange Commission on April&nbsp;19, 2010 (the &#147;Proxy Statement&#148;) and is incorporated by reference
herein. Such summary is qualified in its entirety by reference to the full text of the 2010 Plan,
which is filed as Appendix&nbsp;A to the Proxy Statement. The related form of stock option agreement
and form of restricted stock purchase agreement are filed herewith as Exhibits 10.1 and 10.2,
respectively.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Effective June&nbsp;8, 2010, the Board of Directors of the Company (the &#147;Board&#148;) amended and
restated the Company&#146;s bylaws to (i)&nbsp;clarify that consents and other director communications may be
made by electronic transmission, (ii)&nbsp;remove the seven (7)&nbsp;person limitation on the size of the
Board, (iii)&nbsp;remove reference to the second Tuesday in May as the default date for annual meetings
of stockholders, (iv)&nbsp;revise the methods and timing requirements regarding the giving of notice for
Board meetings and (v)&nbsp;make various technical and typographical changes. A copy of the amended and
restated bylaws of the Company is filed herewith as Exhibit&nbsp;3.1.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;5.05 Amendments to the Registrant&#146;s Code of Ethics, or Waiver of a Provision of the Code of
Ethics.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On June&nbsp;8, 2010, the Board approved revisions to the Company&#146;s whistle blowing policy, which
is incorporated into the Company&#146;s Code of Business Conduct and Ethics and which outlines the
principles and commitments that the Company has made with respect to the treatment of reports by
personnel. The revisions were made to clarify the roles and responsibilities for handling reports,
to add a provision for a third party service provider to whom anonymous reports may be submitted
and to make various technical and typographical changes. A copy of the whistle blowing policy is
available on the Company&#146;s website at www.oncogenex.com.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;5.07 Submission of Matters to a Vote of Security Holders.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On June&nbsp;8, 2010, the Company held its 2010 Annual Meeting at which (i)&nbsp;the six nominees
identified in the table below were elected to the Company&#146;s Board to serve until the Company&#146;s 2011
Annual Meeting of shareholders or until successors are duly elected and qualified, (ii)&nbsp;the
appointment of Ernst &#038; Young LLP as the Company&#146;s independent auditor for the current fiscal year
was ratified (the &#147;Auditor Ratification&#148;), (iii)&nbsp;the 2010 Plan was approved and (iv)&nbsp;the amendment
to the Company&#146;s certificate of incorporation to increase the number of authorized shares of common
stock of the Company to 25,000,000 (a copy of which is filed herewith as Exhibit&nbsp;3.2 (the
&#147;Certificate of Amendment&#148;)) was approved. The matters acted upon at the 2010 Annual Meeting are
described in more detail in the Proxy Statement. Set forth below are the final voting tallies for
the 2010 Annual Meeting:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="58%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Proposal: Election of Directors</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>For</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Withheld</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Broker Non-Vote</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Scott Cormack</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,997,878</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65,997</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,469,760</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Michelle Burris</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,998,014</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65,861</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,469,760</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Neil Clendeninn</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,998,053</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65,822</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,469,760</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Jack Goldstein</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,997,270</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66,605</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,469,760</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Martin Mattingly</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,997,463</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66,412</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,469,760</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Stewart Parker</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,997,528</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66,347</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,469,760</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="44%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Proposal:</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>For</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Against</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Abstain</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Broker Non-Vote</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Auditor Ratification</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,477,459</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46,800</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,376</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>2010 Plan</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,927,749</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">122,136</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13,990</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,469,760</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Certificate of Amendment</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,410,682</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,053,391</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,062,659</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;8.01 Other Events.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On June&nbsp;8, 2010, the Board approved non-material revisions to the Company&#146;s Short Term
Incentive Awards Program (the &#147;STIP&#148;). The STIP, as revised, is filed herewith as Exhibit&nbsp;10.3.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">(d)&nbsp;Exhibits
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Fourth Amended and Restated Bylaws of OncoGenex Pharmaceuticals, Inc.</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment of Certificate of Incorporation of OncoGenex Pharmaceuticals, Inc.</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of OncoGenex Pharmaceuticals, Inc. 2010 Stock Option Agreement under the 2010 Performance
Incentive Plan</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of OncoGenex Pharmaceuticals, Inc. 2010 Restricted Stock Purchase Agreement under the
2010 Performance Incentive Plan</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">OncoGenex Pharmaceuticals, Inc. Short Term Incentive Awards Program</DIV></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SIGNATURES</B><BR>
&nbsp;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>
&nbsp;
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>ONCOGENEX PHARMACEUTICALS, INC.</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" valign="top" align="left">(Registrant)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Date: June&nbsp;14, 2010 &nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">/s/ Cameron Lawrence</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp; &nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cameron Lawrence</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp; &nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Principal Financial Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXHIBIT INDEX</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Fourth Amended and Restated Bylaws of OncoGenex Pharmaceuticals, Inc.</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment of Certificate of Incorporation of OncoGenex Pharmaceuticals, Inc.</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of OncoGenex Pharmaceuticals, Inc. 2010 Stock Option Agreement under the 2010 Performance
Incentive Plan</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of OncoGenex Pharmaceuticals, Inc. 2010 Restricted Stock Purchase Agreement under the
2010 Performance Incentive Plan</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">OncoGenex Pharmaceuticals, Inc. Short Term Incentive Awards Program</DIV></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>c02409exv3w1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 3.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;3.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FOURTH AMENDED AND RESTATED</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>BYLAWS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>OF</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>ONCOGENEX PHARMACEUTICALS, INC.</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;1. Law, Certificate of Incorporation and Bylaws.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">1.1. These bylaws are subject to the certificate of incorporation of the corporation. In
these bylaws, references to law, the certificate of incorporation and bylaws mean the law, the
provisions of the certificate of incorporation and the bylaws as from time to time in effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;2. Stockholders.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.1. <U>Annual Meeting</U>. The annual meeting of stockholders shall be held at such date
and time as shall be designated from time to time by the board of directors and stated in the
notice of the meeting, at which they shall elect a board of directors and transact such other
business as may be required by law or these bylaws or as may properly come before the meeting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.2. <U>Special Meetings</U>. A special meeting of the stockholders may be called at any
time by the chairman of the board, if any, the president or the board of directors. A special
meeting of the stockholders shall be called by the secretary, or in the case of the death, absence,
incapacity or refusal of the secretary, by an assistant secretary or some other officer, upon
application of a majority of the directors. Any such application shall state the purpose or
purposes of the proposed meeting. Any such call shall state the place, date, hour, and purposes of
the meeting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.3. <U>Place of Meeting</U>. All meetings of the stockholders for the election of directors
or for any other purpose shall be held at such place within or without the State of Delaware as may
be determined from time to time by the chairman of the board, if any, the president or the board of
directors. Any adjourned session of any meeting of the stockholders shall be held at the place
designated in the vote of adjournment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.4. <U>Notice of Meetings</U>. Except as otherwise provided by law, a written notice of
each meeting of stockholders stating the place, day and hour thereof and, in the case of a special
meeting, the purposes for which the meeting is called, shall be given not less than ten nor more
than sixty days before the meeting, to each stockholder entitled to vote thereat, and to each
stockholder who, by law, by the certificate of incorporation or by these bylaws, is entitled to
notice, by leaving such notice with him or at his residence or usual place of business, or by
depositing it in the United States mail, postage prepaid, and addressed to such stockholder at his
address as it appears in the records of the corporation. Such notice shall be given by the
secretary, or by an officer or person designated by the board of directors, or in the case of a
special meeting by the officer calling the meeting. As to any adjourned session of any meeting of
stockholders, notice of the adjourned meeting need not be given if the time and place</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">thereof are
announced at the meeting at which the adjournment was taken except that if the adjournment is for more than thirty days or if after the adjournment a new record date is set for the
adjourned session, notice of any such adjourned session of the meeting shall be given in the manner
heretofore described. No notice of any meeting of stockholders or any adjourned session thereof
need be given to a stockholder if a written waiver of notice, executed before or after the meeting
or such adjourned session by such stockholder, is filed with the records of the meeting or if the
stockholder attends such meeting without objecting at the beginning of the meeting to the
transaction of any business because the meeting is not lawfully called or convened. Neither the
business to be transacted at, nor the purpose of, any meeting of the stockholders or any adjourned
session thereof need be specified in any written waiver of notice.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.5. <U>Quorum of Stockholders</U>. At any meeting of the stockholders a quorum as to any
matter shall consist of a majority of the votes entitled to be cast on the matter, except where a
larger quorum is required by law, by the certificate of incorporation or by these bylaws. Any
meeting may be adjourned from time to time by a majority of the votes properly cast upon the
question, whether or not a quorum is present. If a quorum is present at an original meeting, a
quorum need not be present at an adjourned session of that meeting. Shares of its own stock
belonging to the corporation or to another corporation, if a majority of the shares entitled to
vote in the election of directors of such other corporation is held, directly or indirectly, by the
corporation, shall neither be entitled to vote nor be counted for quorum purposes; provided,
however, that the foregoing shall not limit the right of any corporation to vote stock, including
but not limited to its own stock, held by it in a fiduciary capacity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.6. <U>Action by Vote</U>. When a quorum is present at any meeting, a plurality of the
votes properly cast for election to any office shall elect to such office and a majority of the
votes properly cast upon any question other than an election to an office shall decide the
question, except when a larger vote is required by law, by the certificate of incorporation or by
these bylaws. No ballot shall be required for any election unless requested by a stockholder
present or represented at the meeting and entitled to vote in the election.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.7. <U>Proxy Representation</U>. Every stockholder may authorize another person or persons
to act for him by proxy in all matters in which a stockholder is entitled to participate, whether
by waiving notice of any meeting, objecting to or voting or participating at a meeting, or
expressing consent or dissent without a meeting. Every proxy must be signed by the stockholder or
by his attorney-in-fact. No proxy shall be voted or acted upon after three years from its date
unless such proxy provides for a longer period. A duly executed proxy shall be irrevocable if it
states that it is irrevocable and, if, and only as long as, it is coupled with an interest
sufficient in law to support an irrevocable power. A proxy may be made irrevocable regardless of
whether the interest with which it is coupled is an interest in the stock itself or an interest in
the corporation generally. The authorization of a proxy may but need not be limited to specified
action, provided, however, that if a proxy limits its authorization to a meeting or meetings of
stockholders, unless otherwise specifically provided such proxy shall entitle the holder thereof to
vote at any adjourned session but shall not be valid after the final adjournment thereof.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.8. <U>Inspectors</U>. The directors or the person presiding at the meeting may, but need
not, appoint one or more inspectors of election and any substitute inspectors to act at the meeting
or any adjournment thereof. Each inspector, before entering upon the discharge of his duties,
shall take and sign an oath faithfully to execute the duties of inspector at such meeting with
strict
impartiality and according to the best of his ability. The inspectors, if any, shall
determine the number of shares of stock outstanding and the voting power of each, the shares of
stock represented at the meeting, the existence of a quorum, the validity and effect of proxies,
and shall receive votes, ballots or consents, hear and determine all challenges and questions
arising in connection with the right to vote, count and tabulate all votes, ballots or consents,
determine the result, and do such acts as are proper to conduct the election or vote with fairness
to all stockholders. Notwithstanding the foregoing, in the event that a stockholder seeks to
nominate one or more directors pursuant to Section&nbsp;3.3 of these bylaws, the directors shall appoint
two inspectors, who shall not be affiliated with the Corporation, to determine whether a
stockholder has complied with Section&nbsp;3.3 of these bylaws. If the inspector shall determine that a
stockholder has not complied with Section&nbsp;3.3 of these bylaws, the inspectors shall direct the
person presiding over the meeting to declare to the meeting that a nomination was not made in
accordance with the procedures prescribed by the bylaws; and the person presiding over the meeting
shall so declare to the meeting and the defective nomination shall be disregarded. On request of
the person presiding at the meeting, the inspectors shall make a report in writing of any
challenge, question or matter determined by them and execute a certificate of any fact found by
them.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.9. <U>List of Stockholders</U>. The secretary shall prepare and make, at least ten days
before every meeting of stockholders, a complete list of the stockholders entitled to vote at such
meeting, arranged in alphabetical order and showing the address of each stockholder and the number
of shares registered in his name. The stock ledger shall be the only evidence as to who are
stockholders entitled to examine such list or to vote in person or by proxy at such meeting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;3. Board of Directors.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.1. <U>Number</U>. The number of directors which shall constitute the whole board shall not
be less than three (3). The exact number of directors shall be fixed from time to time by a
resolution adopted by a majority of directors. The number of directors may be increased at any
time or from time to time by the directors by vote of a majority of the directors then in office.
The number of directors may be decreased to any number permitted by the foregoing at any time by
the directors by vote of a majority of the directors then in office, but only to eliminate
vacancies existing by reason of the death, resignation or removal of one or more directors.
Directors need not be stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.2. <U>Tenure</U>. Except as otherwise provided by law, by the certificate of incorporation
or by these bylaws, each director shall hold office until the successors of such director&#146;s class
are elected and qualified, or until he sooner dies, resigns, is removed or becomes disqualified.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.3. <U>Nomination</U>. Only persons who are nominated in accordance with the procedures set
forth in this Section&nbsp;3.3 shall be eligible for election as directors. Nominations of persons for
election to the board of directors may be made by or at the direction of the board of directors or
by any stockholder of the corporation entitled to vote for the election of directors at the meeting
who complies with the notice procedures set forth in this Section&nbsp;3.3. Such nominations, other
than those made by or at the discretion of the board of directors, shall be made pursuant to timely
notice in writing to the Secretary. To be timely, a stockholder&#146;s notice shall be delivered to or
mailed and received at the principal executive offices of the corporation not less than 45&nbsp;days nor
more than 90&nbsp;days prior to the meeting; provided, however, that in the event that less than 55
days&#146; notice or prior public disclosure of the date of the meeting is given or made to
stockholders, notice by the stockholder to be timely must be so received not later than the close
of business on the 10th day following the date on which such notice of the date of the meeting was
mailed or such public disclosure was made. Such stockholder&#146;s notice shall set forth (A)&nbsp;as to
each person whom the stockholder proposes to nominate for election or reelection as a director, (i)
the name, age, business address and residence address of such person, (ii)&nbsp;the principal occupation
or employment of such person, (iii)&nbsp;the class and number of shares of the capital stock of the
corporation which are beneficially owned by such person and (iv)&nbsp;any other information relating to
such person that would be required to be disclosed in solicitations of proxies for election of
directors, or would be otherwise required, in each case pursuant to Regulation&nbsp;14A promulgated
under the Securities Exchange Act of 1934, as amended (including without limitation such person&#146;s
written consent to being named in the proxy statement as a without limitation such person&#146;s written
consent to being named in the proxy statement as a nominee and to serving as a director if
elected); and (B)&nbsp;as to the stockholder giving the notice (i)&nbsp;the name and address of such
stockholder and (ii)&nbsp;the class and number of shares of the capital stock of the corporation which
are beneficially owned (as defined by Rule&nbsp;13d-3 of the Securities Exchange Act of 1934, as
amended) by such stockholder. If requested in writing by the Secretary at least 15&nbsp;days in advance
of the annual meeting, a stockholder whose shares are not registered in the name of such
stockholder on the corporation&#146;s books shall provide the Secretary, within ten days of such
request, with documentary support for such claim of beneficial ownership. At the request of the
board of directors, any person nominated by the board of directors for election as a director shall
furnish to the Secretary that information required to be set forth in a stockholder&#146;s notice of
nomination which pertains to the nominee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.4. <U>Powers</U>. The business and affairs of the corporation shall be managed by or under
the direction of the board of directors who shall have and may exercise all the powers of the
corporation and do all such lawful acts and things as are not by law, the certificate of
incorporation or these bylaws directed or required to be exercised or done by the stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.5. <U>Vacancies</U>. Vacancies and any newly created directorships resulting from any
increase in the number of directors may be filled by vote of the stockholders at a meeting called
for the purpose, or by a majority of the directors then in office, although less than a quorum, or
by a sole remaining director. When one or more directors shall resign from the board, effective at
a future date, a majority of the directors then in office, including those who have resigned, shall
have power to fill such vacancy or vacancies, the vote or action by writing thereon to take effect
when such resignation or resignations shall become effective. The directors shall have and may
exercise all their powers notwithstanding the existence of one or more vacancies in their number,
subject to any requirements of law or of the certificate of incorporation or of these bylaws as to
the number of directors required for a quorum or for any vote or other actions.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.6. <U>Committees</U>. The board of directors may, by vote of a majority of the whole
board, (a)&nbsp;designate, change the membership of or terminate the existence of any committee or
committees, each committee to consist of one or more of the directors; (b)&nbsp;designated one or more
directors as alternate members of any such committee who may replace any absent or disqualified
member at any meeting of the committee; and (c)&nbsp;determine the extent to which each such committee
shall have and may exercise the powers of the board of directors in the
management of the business and affairs of the corporation, including the power to authorize
the seal of the corporation to be affixed to all papers which require it and the power and
authority to declare dividends or to authorize the issuance of stock; excepting, however, such
powers which by law, by the certificate of incorporation or by these or by these bylaws they are
prohibited from so delegating. In the absence or disqualification of any member of such committee
and his alternate, if any, the member or members thereof present at any meeting and not
disqualified from voting, whether or not constituting a quorum, may unanimously appoint another
member of the board of directors to act at the meeting in the place of any such absent or
disqualified member. Except as the board of directors may otherwise determine, any committee may
make rules for the conduct of its business, but unless otherwise provided by the board or such
rules, its business shall be conducted as nearly as may be in the same manner as is provided by
these bylaws for the conduct of business by the board of directors. Each committee shall keep
regular minutes of its meetings and report the same to the board of directors upon request.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.7. <U>Regular Meetings</U>. Regular meetings of the board of directors may be held without
call or notice at such places within or without the State of Delaware and at such times as the
board may from time to time determine, provided that notice of the first regular meeting following
any such determination shall be given to absent directors. A regular meeting of the directors may
be held without call or notice immediately after and at the same place as the annual meeting of the
stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.8. <U>Special Meetings</U>. Special meetings of the board of directors may be held at any
time and at any place within or without the State of Delaware designated in the notice of the
meting, when called by the chairman of the board, if any, the president, or by one-third or more in
number of the directors, reasonable notice thereof being given to each director by the secretary or
by the chairman of the board, if any, the president or any one of the directors calling the
meeting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.9 <U>Notice</U>. Any time it is necessary to give notice of a board of directors&#146; meeting,
notice shall be given (i)&nbsp;in person or by telephone to the director at least 24 hours in advance of
the meeting, (ii)&nbsp;by personally delivering written notice to the director&#146;s last known business or
home address at least 24 hours in advance of the meeting, (iii)&nbsp;by delivering an electronic
transmission (including, without limitation, via telefacsimile or electronic mail) to the
director&#146;s last known number or address for receiving electronic transmissions of that type at
least 24 hours in advance of the meeting, (iv)&nbsp;by depositing written notice with a reputable
delivery service or overnight carrier addressed to the director&#146;s last known business or home
address for delivery to that address no later than the business day preceding the date of the
meeting or (v)&nbsp;by depositing written notice in the U.S. mail, postage prepaid, addressed to the
director&#146;s last known business or home address no later than the third business day preceding the
date of the meeting. Notice of a meeting need not be given to any director if a written waiver of
notice, executed by him, or a waiver sent by electronic transmission by him, in either case before
or after the meeting, is filed with the records of the meeting, or to any director who attends the
meeting without protesting prior thereto or at its commencement the lack of notice to him. Neither
notice of a meeting nor a wavier of a notice need specify the purposes of the meeting.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-5-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.10. <U>Quorum</U>. Except as may be otherwise provided by law, by the certificate of
incorporation or these bylaws, at any meeting of the directors a majority of the directors then in
office shall constitute a quorum; a quorum shall not in any case be less than one-third of the
total number of directors constituting the whole board. Any meeting may be adjourned from time to
time by a majority of the votes cast upon the question, whether or not a quorum is present, and the
meeting may be held as adjourned without further notice.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.11. <U>Action by Vote</U>. Except as may be otherwise provided by law, by the certificate
of incorporation or by these bylaws, when a quorum is present at any meeting the vote of a majority
of the directors present shall be the act of the board of directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.12. <U>Action Without a Meeting</U>. Any action required or permitted to be taken at any
meeting of the board of directors or a committee thereof may be taken without a meeting if all the
members of the board or of such committee, as the case may be, consent thereto in writing or by
electronic transmission, and such writing or writings or electronic transmission or transmissions
are filed with the records of the meetings of the board or of such committee. Such consent shall
be treated for all purposes as the act of the board or of such committee, as the case may be.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.13. <U>Participation in Meetings by Conference Telephone</U>. Members of the board of
directors, or any committee designated by such board, may participate in a meeting of such board or
committee by means of conference telephone or similar communications equipment by means of which
all persons participating in the meting can hear each other or by any other means permitted by law.
Such participation shall constitute presence in person at such meeting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.14. <U>Compensation</U>. In the discretion of the board of directors, each director may be
paid such fees for his services as director and be reimbursed from his reasonable expenses incurred
in the performance of his duties as director as the board of directors from time to time may
determine. Nothing contained in this section shall be construed to preclude any director from
serving the corporation in any other capacity and receiving reasonable compensation therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%">3.15. <U>Interested Directors and Officers</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(a)&nbsp;No contract or transaction between the corporation and one or more of its directors or
officers, or between the corporation and any other corporation, partnership, association, or other
organization in which one or more of the corporation&#146;s directors or officers are directors or
officers, or have a financial interest, shall be void or voidable, solely for this reason, or
solely because the director officer is present at or participates in the meeting of the board or
committee thereof which authorizes the contract or transaction, or solely because his or their
votes are counted for such purpose, if:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%">(1)&nbsp;The material facts as to his relationship or interest and as to the contract or
transaction are disclosed or are known to the board of directors or the committee, and the board or
committee in good faith authorizes the contract or transaction by the affirmative votes of majority
of the disinterested directors, even though the disinterested directors be less than a quorum: or
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 12%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-6-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%">(2)&nbsp;The material facts as to his relationship or interest and as to the contract or
transaction are disclosed or are known to the stockholder entitled to vote thereon, and the
contract or transaction is specifically approved in good faith by vote of the stockholders; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%">(3)&nbsp;The contract or transaction is fair as to the corporation as of the time it is authorized,
approved or ratified by the board of directors, a committee thereof, or the stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(b)&nbsp;Common or interested directors may be counted in determining the presence of a quorum at a
meeting of the board of directors or of a committee which authorized the contract or transaction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;4. Officers and Agents.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">4.1. <U>Enumeration: Qualification</U>. The officers of the corporation shall be a
president, a treasurer, a secretary and such other officers, if any, as the board of directors from
time to time may in its discretion elect or appoint including without limitation a chairman of the
board, one or more vice presidents and a controller. The corporation may also have such agents, if
any, as the board of directors from time to time may in its discretion choose. Any officer may be
but none need be a director or stockholder. Any two or more offices may be held by the same
person. Any officer may be required by the board of directors to secure the faithful performance
of his duties to the corporation by giving bond in such amount and with sureties or otherwise as
the board of directors may determine.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">4.2. <U>Powers</U>. Subject to law, to the certificate of incorporation and to the other
provisions of these bylaws, each officer shall have, in addition to the duties and powers herein
set forth, such duties and powers as are commonly incident to his office and such additional duties
and powers as the board of directors may from time to time designate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">4.3. <U>Election</U>. The officers may be elected by the board of directors at their first
meeting following the annual meeting of the stockholders or at any other time. At any time or from
time to time the directors may delegate to any officer their power to elect or appoint any other
officer or any agents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">4.4. <U>Tenure</U>. Each officer shall hold office until the first meeting of the board of
directors following the next annual meeting of the stockholders and until his respective successor
is chosen and qualified unless a shorter period shall have been specified by the terms of his
election or appointment, or in each case until he sooner dies, resigns, is removed or becomes
disqualified. Each agent shall retain his authority at the pleasure of the directors, or the
officer by whom he was appointed or by the officer who then holds agent appointive power.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">4.5. <U>Chairman of the board of directors, President and Vice President</U>. The chairman
of the board, if any, shall have such duties and powers as shall be designated from time to time by
the board of directors. Unless the board of directors otherwise specifies, the chairman of the
board, or if there is none the chief executive officer, shall preside, or designate the person who
shall preside, at all meetings of the stockholders and of the board of directors.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-7-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Unless the board of directors otherwise specifies, the president shall be the chief executive
officer and shall have direct charge of all business operations of the corporation and, subject to
the control of the directors, shall have general charge and supervision of the business of the
corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Any vice president shall have such duties and powers as shall be set forth in these bylaws or
as shall be designated from time to time by the board of directors or by the president.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">4.6. <U>Chief Financial Officer and Assistant Treasurers</U>. Unless the board of directors
otherwise specifies, the chief financial officer shall be the treasurer of the corporation and
shall be in charge of its funds and valuable papers, and shall have such other duties and powers as
may be designated from time to time by the board of directors or by the president. If no
controller is elected, the chief financial officer shall, unless the board of directors otherwise
specifies, also have the duties and powers of the controller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Any assistant treasurers shall have such duties and powers as shall be designated from time to
time by the board of directors, the president or the chief financial officer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">4.7. <U>Controller and Assistant Controller</U>. If a controller is elected, he shall,
unless the board of directors otherwise specifies, be the chief accounting officer of the
corporation and be in charge of its books of account and accounting records, and of its accounting
procedures. He shall have such other duties and powers and may be designated from time to time by
the board of directors, the president or the treasurer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Any assistant controller shall have such duties and powers as shall be designated from time to
time by the board of directors, the president, the treasurer or the controller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">4.8. <U>Secretary and Assistant Secretaries</U>. The secretary shall record all proceedings
of the stockholders, of the board of directors and of committees of the board of directors in a
book or series of books to be kept therefore and shall file therein all actions by written consent
of stockholders or directors. In the absence of the secretary from any meeting, an assistant
secretary, or if there be none or he is absent, a temporary secretary chosen at the meeting, shall
record the proceedings thereof. Unless a transfer agent has been appointed the secretary shall
keep or cause to be kept the stock and transfer records of the corporation, which shall contain the
names and record addresses of all stockholders and the number of shares registered in the name of
each stockholder. He shall have such other duties and powers as may from time to time be
designated by the board of directors or the president.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Any assistant secretaries shall have such duties and powers as shall be designated from time
to time by the board of directors, the president or the secretary.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-8-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;5. Resignations and Removals.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">5.1. Any director or officer may resign at any time by delivering his resignation in writing
or by electronic transmission to the chairman of the board, if any, the president, or the secretary
or to a meeting of the board of directors. Such resignation shall be effective upon receipt unless
specified to be effective at some other time, and without in either case the necessity of its being
accepted unless the resignation shall so state. A director (including persons
elected by directors to fill vacancies in the board) may be removed from office with or
without cause by the vote of the holders of a majority of the shares issued and outstanding and
entitled to vote in the election of directors. The board of directors may at any time remove any
officer either with or without cause. The board of directors may at any time terminate or modify
the authority of any agent. No director of officer resigning and (except where a right to receive
compensation shall be expressly provided in a duly authorized written agreement with the
corporation) no director or officer removed shall have any right to any compensation as such
director or officer for any period following his resignation or removal, or any right to damages on
account of such removal, whether his compensation be by the month or by the year or otherwise;
unless, in the case of a resignation, the directors, or, in the case of removal, the body acting on
the removal, shall in their or its discretion provide for compensation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;6. Vacancies.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">6.1. If the office of the president or the treasurer or the secretary becomes vacant, the
directors may elect a successor by vote of a majority of the directors then in office. If the
office of any other officer becomes vacant, any person or body empowered to elect or appoint that
officer may choose a successor. Each such successor shall hold office for the unexpired term, and
in the case of the president, the treasurer and the secretary until his successor is chosen and
qualified or in each case he sooner dies, resigns, is removed or becomes disqualified. Any vacancy
of a directorship shall be filled as specified in Section&nbsp;3.5 of these bylaws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;7. Capital Stock.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">7.1. <U>Stock Certificates</U>. The shares of the corporation shall be represented by
certificates, provided that the board of directors of the corporation may provide by resolution or
resolutions that some or all of any or all classes or series of its stock shall be uncertificated
shares. Any such resolution shall not apply to shares represented by a certificate until such
certificate is surrendered to the corporation. Notwithstanding the adoption of such a resolution
by the board of directors, every holder of stock represented by certificates and upon request every
holder of uncertificated shares shall be entitled to have a certificate signed by, or in the name
of the corporation by the chairman or vice-chairman of the board of directors, if any, or the
president or vice-president, and by the treasurer or an assistant treasurer, or by the secretary or
an assistant secretary of such corporation representing the number of shares registered in
certificate form. Any or all of the signatures on the certificate may be a facsimile. In case any
officer, transfer agent or registrar who has signed or whose facsimile signature has been placed
upon a certificate has ceased to be such officer, transfer agent or registrar before such
certificate is issued, it may be issued by the corporation with the same effect as if he were such
officer, transfer agent, or registrar at the time of issue.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">7.2. <U>Loss of Certificates</U>. In the case of the alleged theft, loss, destruction or
mutilation of a certificate of stock, a duplicate certificate may be issued in place thereof, upon
such terms, including receipt of a bond sufficient to indemnify the corporation against any claim
on account thereof, as the board of directors may prescribe.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-9-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;8. Transfer of Shares of Stock.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">8.1. <U>Transfer on Books</U>. Subject to the restrictions, if any, stated or noted on the
stock certificate, shares of stock may be transferred on the books of the corporation by the
surrender to the corporation or its transfer agent of the certificate therefor properly endorsed or
accompanied by a written assignment and power of attorney properly executed, with necessary
transfer stamps affixed, and with such proof of the authenticity of signature as the board of
directors or the transfer agent of the corporation may reasonably require. Except as may be
otherwise required by law, by the certificate of incorporation or by these bylaws, the corporation
shall be entitled to treat the record holder of stock as shown on its books as the owner of such
stock for all purposes, including the payment of dividends and the right to receive notice and to
vote or to give any consent with respect thereto and to be held liable for such calls and
assessments, if any, as may lawfully be made thereon, regardless of any transfer, pledge or other
disposition of such stock until the shares have been properly transferred on the books of the
corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">It shall be the duty of each stockholder to notify the corporation of his post office address.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">8.2. <U>Record Date and Closing Transfer Books</U>. In order that the corporation may
determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any
adjournment thereof, the board of directors may fix a record date, which record date shall not
precede the date upon which the resolution fixing the record date is adopted by the board of
directors, and which record date shall not be more than sixty nor less than ten days before the
date of such meeting. If no such record date is fixed by the board of directors, the record date
for determining the stockholders entitled to notice of or to vote at a meeting of stockholders
shall be at the close of business on the day next preceding the day on which notice is given, or,
if notice is waived, at the close of business on the day next preceding the day on which the
meeting is held. A determination of stockholders or record entitled to notice of or to vote at a
meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the
board of directors may fix a new record date for the adjourned meeting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">In order that the corporation may determine the stockholders entitled to receive payment of
any dividend or other distribution or allotment of any rights or to exercise any rights in respect
of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the
board of directors may fix a record date, which record date shall not precede the date upon which
the resolution fixing the record date is adopted, and which record date shall be not more than
sixty days prior to such payment, exercise or other action. If no such record date is fixed, the
record date for determining stockholders for any such purpose shall be at the close of business on
the day on which the board of directors adopts the resolution relating thereto.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-10-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;9. Indemnification.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">9.1. <U>Right to Indemnification</U>. Each person who was or is made a party or is
threatened to be made a party to or is otherwise involved in any action, suit or proceeding,
whether civil, criminal, administrative or investigative (hereinafter a &#147;proceeding&#148;), by reason of
the fact that he or she is or was a director officer of the corporation or is or was serving at the
request of the corporation as a director or officer of another corporation or of a partnership,
joint
venture, trust or other enterprise, including service with respect to employee benefit plans
(hereinafter an &#147;indemnitee&#148;), whether the basis of such proceeding is alleged action in an
official capacity as a director or officer or in any other capacity while serving as a director or
officer, shall be indemnified and held harmless by the corporation to the fullest extent authorized
by the Delaware General Corporation Law, as the same exists or may hereafter be amended (but, in
the case of any such amendment, only to the extent that such amendment permits the corporation to
provide broader indemnification rights than such law permitted the corporation to provide prior to
such amendment), against all expense, liability and loss (including attorneys&#146; fees, judgments,
fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or
suffered by such indemnitee in connection therewith and such indemnification shall continue as to
an indemnitee who has ceased to be a director or officer and shall inure to the benefit of the
indemnitee&#146;s heirs, executors and administrators; provided, however, that, except as provided in
this Section&nbsp;9.1 with respect to proceedings to enforce rights to indemnification, the corporation
shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by
such indemnitee only if such proceeding (or part thereof) was authorized by the board of directors
of the corporation. The right to indemnification conferred in this Section&nbsp;9.1 shall be a contract
right and shall include the right to be paid by the corporation the expenses incurred in defending
any such proceeding in advance of its final disposition (hereinafter an &#147;advancement of expenses&#148;);
provided, however, that, if the Delaware General Corporation Law requires, an advancement of
expenses incurred by an indemnitee in his or her capacity as a director or officer (and not in any
other capacity in which service was or is rendered by such indemnitee, including without
limitation, service to an employee benefit plan) shall be made only upon delivery to the
corporation of an undertaking, by or on behalf of such indemnitee, to repay all amounts so advanced
if it shall ultimately be determined by final judicial decision from which there is not further
right to appeal that such indemnitee is not entitled to be indemnified for such expenses under this
Section&nbsp;9 or otherwise (hereinafter an &#147;undertaking&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">9.2. <U>Right of Indemnitee to Bring Suit</U>. If a claim under Section&nbsp;9.1 of these bylaws
is not paid in full by the corporation within forty-five (45)&nbsp;days after a written claim has been
received by the corporation, the indemnitee may at any time thereafter bring suit against the
corporation to recover the unpaid amount of the claim. If successful in whole or part in any such
suit or in a suit brought by the corporation to recover an advancement of expenses pursuant to the
terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of
prosecuting or defending such suit. In (i)&nbsp;any suit brought by the indemnitee to enforce a right
to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an
advancement of expenses) it shall be a defense that, and (ii)&nbsp;any suit by the corporation to
recover an advancement of expenses pursuant to the terms of an undertaking the corporation shall be
entitled to recover such expenses upon a final adjudication that, the indemmitee has not met the
applicable standard of conduct set forth in the Delaware General Corporation Law. Neither the
failure of the corporation (including its board of directors, independent legal counsel, or its
stockholders) to have made a determination prior to the commencement of such suit that
indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the
applicable standard of conduct set forth in the Delaware General Corporation Law, nor an actual
determination by the corporation (including its board of directors, independent legal counsel, or
its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create
a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of
such a suit brought by indemnitee, be a defense to such suit. In any suit brought by
the indemnitee to enforce a right hereunder, or by the corporation to recover an advancement
of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is
not entitled to be indemnified or to such advancement of expenses under this Section&nbsp;9 or otherwise
shall be on the corporation.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-11-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">9.3. <U>Non-Exclusivity of Rights</U>. The rights of indemnification and to the advancement
of expenses conferred in this Section&nbsp;9 shall not be exclusive of any other right which any person
may have or thereafter acquire under any statue, provision of the Certificate of Incorporation,
by-law agreement, vote of stockholders or disinterested directors or otherwise and shall inure to
the benefit of the heirs and legal representatives of such person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">9.4. <U>Insurance</U>. The corporation may maintain insurance, at its expense, to protect
itself and any director, officer, employee or agent of the corporation or another corporation,
partnership, joint venture, trust or other enterprise against any expense, liability or loss,
whether or not the corporation would have the power to indemnify such person against such expense,
liability or loss under the Delaware General Corporation Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">9.5. <U>Indemnification of Employees or Agents of the Corporation</U>. The corporation may,
to the extent authorized from time to time by the board of directors, grant rights to
indemnification and to the advancement of expenses, to any employee or agent of the corporation to
the fullest extent of the provisions of this Section&nbsp;9 with respect to the indemnification and
advancement of expenses of directors or officers of the corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">9.6. <U>Indemnification Contracts</U>. The board of directors is authorized to enter into a
contract with any director, officer, employee or agent of the corporation, or any person serving at
the request of the corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, including employee benefit plans, providing
for indemnification rights equivalent to or, if the board of directors so determines, greater than,
those provided for in this Section&nbsp;9.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">9.7. <U>Effect of Amendment</U>. Any amendment, repeal or modification of any provision of
this Section&nbsp;9 by the stockholders or the directors of the corporation shall not adversely affect
any right or protection of a director or officer of the corporation existing at the time of such
amendment, repeal or modification.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Section&nbsp;10. General Provisions.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">10.1. <U>Corporate Seal</U>. Subject to alteration by the directors, the seal of the
corporation shall consist of a flat-faced circular die with the word &#147;Delaware&#148; and the name of the
corporation cut or engraved thereon, together with such other words, dates or images as may be
approved from time to time by the directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">10.2. <U>Execution of Papers</U>. Except as the board of directors may generally or in
particular cases authorize the execution thereof in some other manner, all deeds, leases,
transfers, contracts, bonds, notes, checks, drafts or other obligations made, accepted or endorsed
by the corporation shall be signed by the chairman of the board, if any, the president, a vice
president or the treasurer.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-12-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">10.3. <U>Fiscal Year</U>. The fiscal year of the corporation shall be fixed by resolution
of the Board of Directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">10.4. <U>Electronic Transmission</U>. For purposes of these bylaws, &#147;electronic
transmission&#148; shall mean a form of communication not directly involving the physical transmission
of paper that satisfies the requirements with respect to such communications contained in the
Delaware General Corporation Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">10.5. Amendments. These bylaws may be adopted, amended or repealed by vote of a majority of
the directors then in office or by vote of a majority of the stock outstanding and entitled to
vote. Any by-law, whether adopted, amended or repealed by the stockholders or directors, may be
amended or reinstated by the stockholders or the directors.
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->-13-<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>c02409exv3w2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 3.2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;3.2</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CERTIFICATE OF AMENDMENT</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>OF</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CERTIFICATE OF INCORPORATION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>OF</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>ONCOGENEX PHARMACEUTICALS, INC.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>a Delaware Corporation</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">(pursuant to Section&nbsp;242 of the Delaware General Corporation Law)
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">ONCOGENEX PHARMACEUTICALS, INC., a corporation organized and existing under and by the virtue
of the Delaware General Corporation Law (the &#147;Corporation&#148;), through its duly authorized officers
and by authority of its Board of Directors does hereby certify:
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%; text-indent: 4%">FIRST: That in accordance with the provisions of Section&nbsp;242 of the General
Corporation Law of the State of Delaware, the Board of Directors of the Corporation duly
adopted resolutions setting forth a proposed amendment to the Corporation&#146;s certificate of
incorporation, as amended, declaring said amendment to be advisable and directing that said
amendment be submitted to the stockholders of the Corporation for consideration thereof.
The resolution setting forth the proposed amendment is as follows:
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%; text-indent: 4%">RESOLVED, that the first three sentences of the text of Article&nbsp;IV of the
Corporation&#146;s certificate of incorporation, as amended, be deleted and replaced with
the following text:
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%">&#147;This Corporation is authorized to issue two classes of stock to be
designated respectively, &#147;Common Stock&#148; and &#147;Preferred Stock.&#148; The total
number of shares of all classes of stock which the Corporation shall have
authority to issue is 30,000,000, of which (i)&nbsp;25,000,000 shares shall be
designated Common Stock and shall have a par value of $.001 per share; and
(ii)&nbsp;5,000,000 shares shall be designated Preferred Stock and shall have a
par value of $.001 per share.&#148;
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%; text-indent: 4%">SECOND: That thereafter, pursuant to a resolution of its Board of Directors, in
accordance with Section&nbsp;242 of the General Corporation Law of the State of Delaware, the
Corporation&#146;s stockholders approved and authorized the foregoing Certificate of Amendment.
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%; text-indent: 4%">THIRD: That the foregoing Certificate of Amendment was duly adopted in accordance with
the provisions of Section&nbsp;242 of the Delaware General Corporation Law.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">IN WITNESS WHEREOF, this Corporation has caused this Certificate of Amendment to be signed by
Scott Cormack, its duly authorized President and Chief Executive Officer this 8<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of
June, 2010.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ONCOGENEX PHARMACEUTICALS, INC.<BR>
a Delaware Corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Scott Cormack
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Scott Cormack&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>c02409exv10w1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 10.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;10.1</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Option No.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>ONCOGENEX PHARMACEUTICALS, INC.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><U><B>STOCK OPTION AGREEMENT</B></U>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B>Type of Option (check one): </B><FONT face="Wingdings">&#111;</FONT><B> Incentive </B><FONT face="Wingdings">&#111;</FONT><B> Nonqualified</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">This Stock Option Agreement (the &#147;Agreement&#148;) is entered into as of <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
20<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, by and between OncoGenex Pharmaceuticals, Inc., a Delaware corporation (the
&#147;Company&#148;), and <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (the &#147;Optionee&#148;) pursuant to the Company&#146;s
2010 Performance Incentive Plan, as amended (the &#147;Plan&#148;). Any capitalized term not defined herein
shall have the same meaning ascribed to it in the Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>1.&nbsp;</B><U><B>Grant of Option</B></U>. The Company hereby grants to Optionee an option (the &#147;Option&#148;) to
purchase all or any portion of a total of <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>) shares
(the &#147;Shares&#148;) of the Common Stock of the Company at a purchase price of
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> ($<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>) per share (the &#147;Exercise Price&#148;), subject to
the terms and conditions set forth herein and the provisions of the Plan. If the box marked
&#147;Incentive&#148; above is checked, then this Option is intended to qualify as an &#147;incentive stock
option&#148; as defined in Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;).
If this Option fails in whole or in part to qualify as an incentive stock option, or if the box
marked &#147;Nonqualified&#148; is checked, then this Option shall to that extent constitute a nonqualified
stock option.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>2.&nbsp;</B><U><B>Vesting of Option</B></U>. The right to exercise this Option shall vest in installments,
and this Option shall be exercisable from time to time in whole or in part as to any vested
installment, as follows:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="77%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Upon the date set forth below:</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>This Option shall be Exercisable as to:</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Shares</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Shares</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Shares</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">No additional Shares shall vest after the date of termination of Optionee&#146;s &#147;Continuous
Service&#148; (as defined below), but this Option shall continue to be exercisable in accordance with
Section&nbsp;3 hereof with respect to that number of Shares that have vested as of the date of
termination of Optionee&#146;s Continuous Service.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">As used herein, the term &#147;Continuous Service&#148; means (i)&nbsp;employment by either the Company or
any parent or subsidiary corporation of the Company, or by a corporation or a parent or subsidiary
of a corporation issuing or assuming a stock option in a transaction to which Section 424(a) of the
Code applies, which is uninterrupted except for vacations, illness (except for permanent
disability, as defined in Section&nbsp;22(e)(3) of the Code), or leaves of absence which are approved in
writing by the Company or any of such other employer corporations, if applicable, (ii)&nbsp;service as a
member of the Board of Directors of the Company until Optionee resigns, is removed from office, or
Optionee&#146;s term of office expires and he or she is not
reelected, or (iii)&nbsp;so long as Optionee is engaged as a Service Provider to the Company or
other corporation referred to in clause (i)&nbsp;above.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>3.&nbsp;</B><U><B>Term of Option</B></U>. The right of the Optionee to exercise this Option shall terminate
upon the first to occur of the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%">(a)&nbsp;the expiration of ten (10)&nbsp;years from the date of this Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(b)&nbsp;the expiration of three (3)&nbsp;months from the date of termination of Optionee&#146;s Continuous
Service if such termination occurs for any reason other than permanent disability or death;
provided, however, that if Optionee dies during such three-month period the provisions of Section
3(d) below shall apply; and provided, further, that if Section 3(d) does not apply, and on the last
trading day within such three-month period Optionee is subject to a blackout imposed by the Company
pursuant to which Optionee is restricted from exercising this Option or reselling the Shares
issuable upon such exercise, the right of Optionee to exercise this Option shall continue until the
tenth (10<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>) day following the expiration of such blackout with respect to Optionee;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(c)&nbsp;the expiration of one (1)&nbsp;year from the date of termination of Optionee&#146;s Continuous
Service if such termination is due to permanent disability of the Optionee (as defined in Section
22(e)(3) of the Code);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(d)&nbsp;the expiration of one (1)&nbsp;year from the date of termination of Optionee&#146;s Continuous
Service if such termination is due to Optionee&#146;s death or if death occurs during the three-month
period following termination of Optionee&#146;s Continuous Service specified in Section 3(b) above; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(e)&nbsp;upon the consummation of a &#147;Change in Control&#148; (as defined in Section&nbsp;2.7 of the Plan).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>4.&nbsp;</B><U><B>Exercise of Option</B></U>. On or after the vesting of any portion of this Option in
accordance with Sections&nbsp;2 or 8 hereof, and until termination of the right to exercise this Option
in accordance with Section&nbsp;3 above, the portion of this Option which has vested may be exercised in
whole or in part by the Optionee (or, after his or her death, by the person designated in Section&nbsp;5
below) upon delivery of the following to the Company at its principal executive offices:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(a)&nbsp;a written notice of exercise which identifies this Agreement and states the number of
Shares then being purchased (but no fractional Shares may be purchased);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(b)&nbsp;a check or cash in the amount of the Exercise Price (or payment of the Exercise Price in
such other form of lawful consideration as the Administrator may approve from time to time under
the provisions of Section&nbsp;5.3 of the Plan);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(c)&nbsp;a check or cash in the amount reasonably requested by the Company to satisfy the Company&#146;s
withholding obligations under federal, state or other applicable tax laws with respect to the
taxable income, if any, recognized by the Optionee in connection with the exercise of this Option
(unless the Company and Optionee shall have made other arrangements
for deductions or withholding from Optionee&#146;s wages, bonus or other compensation payable to
Optionee, or by the withholding of Shares issuable upon exercise of this Option or the delivery of
Shares owned by the Optionee in accordance with Section&nbsp;11.1 of the Plan, provided such
arrangements satisfy the requirements of applicable tax laws); and
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 2 of 6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(d)&nbsp;a letter, if requested by the Company, in such form and substance as the Company may
require, setting forth the investment intent of the Optionee, or person designated in Section&nbsp;5
below, as the case may be.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>5.&nbsp;</B><U><B>Death of Optionee; No Assignment</B></U>. The rights of the Optionee under this Agreement
may not be assigned or transferred except by will or by the laws of descent and distribution, and
may be exercised during the lifetime of the Optionee only by such Optionee. Any attempt to sell,
pledge, assign, hypothecate, transfer or dispose of this Option in contravention of this Agreement
or the Plan shall be void and shall have no effect. If the Optionee&#146;s Continuous Service
terminates as a result of his or her death, and provided Optionee&#146;s rights hereunder shall have
vested pursuant to Section&nbsp;2 hereof, Optionee&#146;s legal representative, his or her legatee, or the
person who acquired the right to exercise this Option by reason of the death of the Optionee
(individually, a &#147;Successor&#148;) shall succeed to the Optionee&#146;s rights and obligations under this
Agreement. After the death of the Optionee, only a Successor may exercise this Option.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>6.&nbsp;</B><U><B>Representation of Optionee</B></U>. Optionee acknowledges receipt of a copy of the Plan
and understands that all rights and obligations connected with this Option are set forth in this
Agreement and the Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>7.&nbsp;</B><U><B>Adjustments Upon Changes in Capital Structure</B></U>. In the event that the outstanding
shares of Common Stock of the Company are hereafter increased or decreased or changed into or
exchanged for a different number or kind of shares or other securities of the Company by reason of
a recapitalization, stock split, reverse stock split, reclassification, stock dividend or other
similar change in the capital structure of the Company, then appropriate adjustment shall be made
by the Administrator to the number of Shares subject to the unexercised portion of this Option and
to the Exercise Price per Share, in order to preserve, as nearly as practical, but not to increase,
the benefits of the Optionee under this Option, in accordance with the provisions of Section&nbsp;4.2 of
the Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>8.&nbsp;</B><U><B>Change in Control</B></U>. In the event of a Change in Control (as defined in Section&nbsp;2.7
of the Plan), the right to exercise this Option shall accelerate automatically and vest in full
(notwithstanding the provisions of Section&nbsp;2 above) effective as of immediately prior to the
consummation of the Change in Control. If vesting of this Option will accelerate pursuant to the
preceding sentence, the Administrator in its discretion may provide, in connection with the Change
in Control transaction, for the purchase or exchange of this Option for an amount of cash or other
property having a value equal to the difference (or &#147;spread&#148;) between: (x)&nbsp;the value of the cash
or other property that the Optionee would have received pursuant to the Change in Control
transaction in exchange for the Shares issuable upon exercise of this Option had this Option been
exercised immediately prior to the Change in Control, and (y)&nbsp;the aggregate Exercise Price for such
Shares. If the vesting of this Option will accelerate pursuant to this Section&nbsp;8, then the
Administrator shall cause written notice of the Change in Control transaction
to be given to the Optionee not less than fifteen (15)&nbsp;days prior to the anticipated effective
date of the proposed transaction.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 3 of 6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>9.&nbsp;</B><U><B>Rights as Stockholder</B></U>. The Optionee (or transferee of this Option by will or by
the laws of descent and distribution) shall have no rights as a stockholder with respect to any
Shares covered by this Option until such person has duly exercised this Option, paid the Exercise
Price and become a holder of record of the Shares purchased.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>10.&nbsp;</B><U><B>&#147;Market Stand-Off&#148; Agreement</B></U>. Optionee agrees that, if requested by the Company
or the managing underwriter of any proposed public offering of the Company&#146;s securities, Optionee
will not sell or otherwise transfer or dispose of any Shares held by Optionee without the prior
written consent of the Company or such underwriter, as the case may be, during such period of time,
not to exceed 180&nbsp;days following the effective date of the registration statement filed by the
Company with respect to such offering, as the Company or the underwriter may specify.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>11.&nbsp;</B><U><B>Interpretation</B></U>. This Option is granted pursuant to the terms of the Plan, and
shall in all respects be interpreted in accordance therewith. The Administrator shall interpret
and construe this Option and the Plan, and any action, decision, interpretation or determination
made in good faith by the Administrator shall be final and binding on the Company and the Optionee.
As used in this Agreement, the term &#147;Administrator&#148; shall refer to the committee of the Board of
Directors of the Company appointed to administer the Plan, and if no such committee has been
appointed, the term Administrator shall mean the Board of Directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>12.&nbsp;</B><U><B>Limitation of Liability for Nonissuance</B></U>. During the term of the Plan, the Company
agrees at all times to reserve and keep available, and to use its reasonable best efforts to obtain
from any regulatory body having jurisdiction any requisite authority in order to issue and sell,
such number of shares of its Common Stock as shall be sufficient to satisfy its obligations
hereunder and the requirements of the Plan. Inability of the Company to obtain, from any
regulatory body having jurisdiction, authority deemed by the Company&#146;s counsel to be necessary for
the lawful issuance and sale of any shares of its Common Stock hereunder and under the Plan shall
relieve the Company of any liability in respect of the nonissuance or sale of such shares as to
which such requisite authority shall not have been obtained.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>13.&nbsp;</B><U><B>Notices</B></U>. Any notice, demand or request required or permitted to be given under
this Agreement shall be in writing and shall be deemed given when delivered personally or three (3)
days after being deposited in the United States mail, as certified or registered mail, with postage
prepaid, (or by such other method as the Administrator may from time to time deem appropriate), and
addressed, if to the Company, at its principal place of business, Attention: the Chief Financial
Officer, and if to the Optionee, at his or her most recent address as shown in the employment or
stock records of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>14.&nbsp;</B><U><B>Severability</B></U>. Should any provision or portion of this Agreement be held to be
unenforceable or invalid for any reason, the remaining provisions and portions of this Agreement
shall be unaffected by such holding.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 4 of 6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>15.&nbsp;</B><U><B>Counterparts</B></U>. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original and all of which together shall be deemed one instrument.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>16.&nbsp;</B><U><B>Tax Consequences and Reporting Obligation Upon Sale of Shares</B></U>. If this Option is
an &#147;incentive stock option,&#148; the tax benefits afforded to incentive stock options will be obtained
by the Optionee only if the Shares received upon exercise of this Option are held for at least one
year after the date of exercise of this Option and two years after the date this Option was granted
to the Optionee. If the Optionee sells or otherwise transfers the Shares before the expiration of
either of these one- or two-year periods, the sale or transfer will be treated for tax purposes as
a &#147;disqualifying disposition,&#148; resulting in the following tax consequences: (a)&nbsp;the Optionee will
not obtain the tax benefits afforded to incentive stock options, (b)&nbsp;the &#147;spread&#148; as of the date of
exercise will be taxed to the Optionee at ordinary income tax rates, and (c)&nbsp;the amount of ordinary
income resulting from the disqualifying disposition will be included in the Optionee&#146;s W-2. These
tax consequences are described in more detail in the prospectus that relates to the Plan, a copy of
which was delivered to the Optionee with this Option. To assure that the Company has the
information necessary to comply with its tax reporting obligations, Optionee agrees to promptly
notify the Company if any Shares are sold or transferred less than one year after the date of
exercise or less than two years after the date this Option was granted, and report information
regarding the disqualifying disposition in accordance with procedures established by the Company
for this purpose.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 5 of 6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left"><B>ONCOGENEX PHARMACEUTICALS, INC.</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">OPTIONEE</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD colspan="5" valign="top" align="left">a Delaware corporation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Signature)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Name:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Type or print name)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Its:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Address:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 0px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 6 of 6<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>c02409exv10w2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 10.2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;10.2</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>ONCOGENEX PHARMACEUTICALS, INC.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 0pt"><B>RESTRICTED STOCK PURCHASE AGREEMENT</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 0pt"><B>UNDER THE<BR>
2010 PERFORMANCE INCENTIVE PLAN</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">THIS RESTRICTED STOCK PURCHASE AGREEMENT (the &#147;Agreement&#148;) is entered into as of
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>, 20<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> by and between <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (hereinafter
referred to as &#147;Purchaser&#148;), and OncoGenex Pharmaceuticals, Inc., a Delaware corporation
(hereinafter referred to as the &#147;Company&#148;), pursuant to the Company&#146;s 2010 Performance Incentive
Plan, as amended (the &#147;Plan&#148;). Any capitalized term not defined herein shall have the same meaning
ascribed to it in the Plan.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>R E C I T A L S:</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>A.&nbsp;</B>Purchaser is an employee, director, consultant or other Service Provider, and in connection
therewith has rendered services for and on behalf of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>B.&nbsp;</B>The Company desires to issue shares of Common Stock to Purchaser for the consideration set
forth herein to provide an incentive for Purchaser to remain a Service Provider of the Company and
to exert added effort towards its growth and success.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth, and for other
good and valuable consideration, the parties agree as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>1.&nbsp;Issuance of Shares</B>. The Company hereby offers to issue to Purchaser an aggregate of
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;(<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>) shares of Common Stock of the Company (the &#147;Shares&#148;) on the terms and
conditions herein set forth. Unless this offer is earlier revoked in writing by the Company,
Purchaser shall have ten (10)&nbsp;days from the date of the delivery of this Agreement to Purchaser to
accept the offer of the Company by executing and delivering to the Company two copies of this
Agreement, without condition or reservation of any kind whatsoever, together with the consideration
to be delivered by Purchaser pursuant to Section&nbsp;2 below.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>2.&nbsp;Consideration</B>. The purchase price for the Shares shall be $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;per share, or $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
in the aggregate. Any purchase price more than zero shall be paid by the delivery of Purchaser&#146;s
check payable to the Company (or payment in such other form of lawful consideration as the
Administrator may approve from time to time under the provisions of Section&nbsp;6.3 of the Plan).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%"><B>3. Vesting of Shares</B>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(a)&nbsp;</B>Subject to Section 3(b) below, the Shares acquired hereunder shall vest and become &#147;Vested
Shares&#148; as follows:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="77%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Upon the date set forth below:</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Shares that become Vested Shares:</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Shares</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Shares</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Shares</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Shares which have not yet become vested are herein called &#147;Unvested Shares.&#148; No additional Shares
shall vest after the date of termination of Purchaser&#146;s Continuous Service.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">As used herein, the term &#147;Continuous Service&#148; means (i)&nbsp;employment by either the Company or
any parent or subsidiary corporation of the Company, or by any successor entity following a Change
in Control, which is uninterrupted except for vacations, illness (except for permanent disability,
as defined in Section&nbsp;22(e)(3) of the Code), or leaves of absence which are approved in writing by
the Company or any of such other employer corporations, if applicable, (ii)&nbsp;service as a member of
the Board of Directors of the Company until Purchaser resigns, is removed from office, or
Purchaser&#146;s term of office expires and he or she is not reelected, or (iii)&nbsp;so long as Purchaser is
engaged as a consultant or Service Provider to the Company or other corporation referred to in
clause (i)&nbsp;above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(b)&nbsp;</B>Notwithstanding Section&nbsp;3(a), if Purchaser holds Shares at the time a Change in Control
occurs, all Repurchase Rights (as defined below) shall automatically terminate immediately prior to
the consummation of such Change in Control, and the Shares subject to those terminated Repurchase
Rights shall immediately vest in full. If the Repurchase Rights automatically terminate in
accordance with the provisions of this subsection (b), then the Administrator shall cause written
notice of the Change in Control transaction to be given to Purchaser not less than fifteen (15)
days prior to the anticipated effective date of the proposed transaction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%"><B>4. Reconveyance Upon Termination of Service</B>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(a)&nbsp;Repurchase Right</B>. The Company shall have the right (but not the obligation) to repurchase
all or any part of the Unvested Shares (the &#147;Repurchase Right&#148;) in the event that the Purchaser&#146;s
Continuous Service terminates for any reason. Upon exercise of the Repurchase Right, the Purchaser
shall be obligated to sell his or her Unvested Shares to the Company, as provided in this Section
4. If the Purchase Price is zero, then Purchaser shall be obligated to transfer his or her
Unvested Shares to the Company without consideration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(b)&nbsp;Consideration for Repurchase Right</B>. The repurchase price of the Unvested Shares (the
&#147;Repurchase Price&#148;) shall be equal to the Purchase Price, if any, of such Unvested Shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(c)&nbsp;Procedure for Exercise of Reconveyance Option</B>. For sixty (60)&nbsp;days after the date of
termination of Purchaser&#146;s Continuous Service or other event described in this Section&nbsp;4, the
Company may exercise the Repurchase Right by giving Purchaser and/or any other person obligated to
sell written notice of the number of Unvested Shares which the Company desires to purchase. The
Repurchase Price for the Unvested Shares shall be payable, at the option of the Company, by check
or by cancellation of all or a portion of any outstanding indebtedness of Purchaser to the Company,
or by any combination thereof.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 12%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 2 of 7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(d)&nbsp;Notification and Settlement</B>. In the event that the Company has elected to exercise the
Repurchase Right as to part or all of the Unvested Shares within the period described above,
Purchaser or such other person shall deliver to the Company certificate(s) representing the
Unvested Shares to be acquired by the Company within thirty (30)
days following the date of the notice from the Company. The Company shall deliver to
Purchaser against delivery of the Unvested Shares, checks of the Company payable to Purchaser
and/or any other person obligated to transfer the Unvested Shares in the aggregate amount of the
Repurchase Price, if any, to be paid as set forth in Section 4(b) above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(e)&nbsp;Deposit of Unvested Shares</B>. Purchaser shall deposit with the Company certificates
representing the Unvested Shares, together with a duly executed stock assignment separate from
certificate in blank, which shall be held by the Secretary of the Company. Purchaser shall be
entitled to vote and to receive dividends and distributions on all such deposited Unvested Shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(f)&nbsp;Termination</B>. The provisions of this Section&nbsp;4 shall automatically terminate in accordance
with Section 3(b) above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(g)&nbsp;Assignment</B>. The Company may assign its Repurchase Right under this Section&nbsp;4 without the
consent of the Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>5.&nbsp;Restrictions on Unvested Shares</B>. Unvested Shares may not be sold, transferred, pledged, or
otherwise disposed of, except that such Unvested Shares may be transferred to a trust established
for the sole benefit of the Purchaser and/or his or her spouse, children or grandchildren. Any
Unvested Shares that are transferred as provided herein remain subject to the terms and conditions
of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>6.&nbsp;Adjustments Upon Changes in Capital Structure</B>. In the event that the outstanding shares of
Common Stock of the Company are hereafter increased or decreased or changed into or exchanged for a
different number or kind of shares or other securities of the Company by reason of a
recapitalization, stock split, combination of shares, reclassification, stock dividend, or other
change in the capital structure of the Company, then Purchaser shall be entitled to new or
additional or different shares of stock or securities, in order to preserve, as nearly as
practical, but not to increase, the benefits of Purchaser under this Agreement, in accordance with
the provisions of Section&nbsp;4.2 of the Plan. Such new, additional or different shares shall be
deemed &#147;Shares&#148; for purposes of this Agreement and subject to all of the terms and conditions
hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>7.&nbsp;Shares Free and Clear</B>. All Shares purchased by the Company pursuant to this Agreement
shall be delivered by Purchaser free and clear of all claims, liens and encumbrances of every
nature (except the provisions of this Agreement and any conditions concerning the Shares relating
to compliance with applicable federal or state securities laws), and the purchaser thereof shall
acquire full and complete title and right to all of such Shares, free and clear of any claims,
liens and encumbrances of every nature (again, except for the provisions of this Agreement and such
securities laws).
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 3 of 7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%"><B>8. Limitation of Company&#146;s Liability for Nonissuance; Unpermitted Transfers</B>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(a)&nbsp;</B>The Company agrees to use its reasonable best efforts to obtain from any applicable
regulatory agency such authority or approval as may be required in order to issue and sell the
Shares to Purchaser pursuant to this Agreement. The inability of the Company
to obtain, from any such regulatory agency, authority or approval deemed by the Company&#146;s
counsel to be necessary for the lawful issuance and sale of the Shares hereunder and under the Plan
shall relieve the Company of any liability in respect of the nonissuance or sale of such Shares as
to which such requisite authority or approval shall not have been obtained.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><B>(b)&nbsp;</B>The Company shall not be required to: (i)&nbsp;transfer on its books any Shares of the Company
which shall have been sold or transferred in violation of any of the provisions set forth in this
Agreement, or (ii)&nbsp;treat as owner of such Shares or to accord the right to vote as such owner or to
pay dividends to any transferee to whom such Shares shall have been so transferred.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>9.&nbsp;Notices</B>. Any notice, demand or request required or permitted to be given under this
Agreement shall be in writing and shall be deemed given when delivered personally or three (3)&nbsp;days
after being deposited in the United States mail, as certified or registered mail, with postage
prepaid, (or by such other method as the Administrator may from time to time deem appropriate), and
addressed, if to the Company, at its principal place of business, Attention: the Chief Financial
Officer, and if to the Purchaser, at his or her most recent address as shown in the employment or
stock records of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>10.&nbsp;Binding Obligations</B>. All covenants and agreements herein contained by or on behalf of any
of the parties hereto shall bind and inure to the benefit of the parties hereto and their permitted
successors and assigns.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>11.&nbsp;Captions and Section&nbsp;Headings</B>. Captions and section headings used herein are for
convenience only, and are not part of this Agreement and shall not be used in construing it.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>12.&nbsp;Interpretation</B>. All Shares are issued pursuant to the terms of the Plan, and shall in all
respects be interpreted in accordance therewith. The Administrator shall interpret and construe
this Agreement and the Plan, and any action, decision, interpretation or determination made in good
faith by the Administrator shall be final and binding on the Company and the Purchaser. As used in
this Agreement, the term &#147;Administrator&#148; shall refer to the committee of the Board of Directors of
the Company appointed to administer the Plan, and if no such committee has been appointed, the term
Administrator shall mean the Board of Directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>13.&nbsp;Entire Agreement</B>. This Agreement and the Plan constitute the entire agreement between the
parties with respect to the subject matter hereof and supersede all prior or contemporaneous
written or oral agreements and understandings of the parties, either express or implied.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>14.&nbsp;Assignment</B>. Purchaser shall have no right, without the prior written consent of the
Company, to (i)&nbsp;sell, assign, mortgage, pledge or otherwise transfer any interest or right created
hereby, or (ii)&nbsp;delegate his or her duties or obligations under this Agreement. This Agreement is
made solely for the benefit of the parties hereto, and no other person, partnership, association or
corporation shall acquire or have any right under or by virtue of this Agreement.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 4 of 7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>15.&nbsp;Severability</B>. Should any provision or portion of this Agreement be held to be
unenforceable or invalid for any reason, the remaining provisions and portions of this Agreement
shall be unaffected by such holding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>16.&nbsp;Counterparts</B>. This Agreement may be executed in one or more counterparts, all of which
taken together shall constitute one agreement and any party hereto may execute this Agreement by
signing any such counterpart. This Agreement shall be binding upon Purchaser and the Company at
such time as the Agreement, in counterpart or otherwise, is executed by Purchaser and the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>17.&nbsp;&#147;Market Stand-Off&#148; Agreement</B>. Purchaser agrees in connection with any registration of the
Company&#146;s securities that, upon the request of the Company or the underwriters managing any public
offering of the Company&#146;s securities, Purchaser will not sell or otherwise dispose of any Shares
acquired by Purchaser without the prior written consent of the Company or such underwriters, as the
case may be, for a period of time (not to exceed 180&nbsp;days) from the effective date of such
registration as the Company or the underwriters may specify.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>18.&nbsp;Tax Elections</B>. Purchaser understands that Purchaser (and not the Company) shall be
responsible for the Purchaser&#146;s own tax liability that may arise as a result of the acquisition of
the Shares. Purchaser acknowledges that Purchaser has considered the advisability of all tax
elections in connection with the purchase of the Shares, including the making of an election under
Section 83(b) under the Internal Revenue Code of 1986, as amended (&#147;Code&#148;); Purchaser further
acknowledges that the Company has no responsibility for the making of such Section 83(b) election.
In the event Purchaser determines to make a Section 83(b) election, Purchaser agrees to timely
provide a copy of the election to the Company as required under the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>19.&nbsp;Attorneys&#146; Fees</B>. If any party shall bring an action in law or equity against another to
enforce or interpret any of the terms, covenants and provisions of this Agreement, the prevailing
party in such action shall be entitled to recover reasonable attorneys&#146; fees and costs.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 5 of 7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above
written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left"><B>THE COMPANY:</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>PURCHASER:</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD colspan="5" valign="top" align="left">ONCOGENEX PHARMACEUTICALS, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Name:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Print Name)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Title:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Address:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 6 of 7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CONSENT AND RATIFICATION OF SPOUSE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The undersigned, the spouse of <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, a party to the attached Restricted
Stock Purchase Agreement (the &#147;Agreement&#148;), dated as of <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, hereby
consents to the execution of said Agreement by such party; and ratifies, approves, confirms and
adopts said Agreement, and agrees to be bound by each and every term and condition thereof as if
the undersigned had been a signatory to said Agreement, with respect to the Shares (as defined in
the Agreement) made the subject of said Agreement in which the undersigned has an interest,
including any community property interest therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">I also acknowledge that I have been advised to obtain independent counsel to represent my
interests with respect to this Agreement but that I have declined to do so and I hereby expressly
waive my right to such independent counsel.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Date:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Signature)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Print Name)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->Page 7 of 7<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>c02409exv10w3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 10.3</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: Helvetica,Arial,sans-serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;10.3</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>OncoGenex Pharmaceuticals, Inc.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><U><B>Short Term Incentive Awards Program</B></U>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>I. </B><U><B>PURPOSE</B></U>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">The Short Term Incentive Awards Program provides employees of OncoGenex Pharmaceuticals, Inc. (the
&#147;Company&#148;) and its subsidiaries with the annual opportunity to receive a discretionary cash bonus
based on performance related to corporate, team or individual goals and objectives. The Short Term
Incentive Awards Program begins Fiscal Year 2009 and replaces and supersedes prior plans and/or
practices related to bonus compensation, as previously adopted by employment agreement or
otherwise.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>II. </B><U><B>ADMINISTRATION</B></U>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">This Program is administered by the Compensation Committee of the Board of Directors of the Company
(the &#147;Committee&#148;), which may, to the extent permitted by applicable regulations, delegate its
authority to the President &#038; Chief Executive Officer (the &#147;CEO&#148;). All decisions made by the
Committee or by the CEO within the scope of any delegated authority shall be final and binding on
all employees. The Committee retains the right to amend, alter, or terminate this Program at any
time.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>III. </B><U><B>ELIGIBILITY</B></U>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">An employee&#146;s bonus eligibility and the portion of such eligibility attributable to corporate, team
and individual objectives shall be determined annually, with reference to the employee&#146;s pay grade.
The Company maintains a schedule of the bonus eligibility of each pay grade, which the Committee
may amend from time to time.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">Annually, the Committee will recommend to the Board of Directors, and the Board of Directors will
determine, the corporate objectives that will apply for that year and management will determine the
team and individual objectives that will apply for that year.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">To be eligible to participate in this Program with respect to any fiscal year, an employee must
have commenced employment at least three complete calendar months prior to the end of such fiscal
year. To be eligible to receive an award under the Program with respect to such fiscal year, the
employee must remain continuously employed by the Company or a subsidiary of the Company.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>IV. </B><U><B>AWARDS</B></U>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">Annually, the Committee will determine whether the Company&#146;s corporate objectives for the completed
fiscal year were achieved and management will determine for each employee having team or individual
goals whether such employee&#146;s team or individual goals were achieved. If objectives were not
achieved at a 100% level, the Committee (in the case of corporate goals) or the CEO (in the case of
team or individual goals) may, in its, his or her sole discretion, determine (A)&nbsp;that such
objectives were not achieved for purposes of this Program and that the applicable bonuses will
therefore not be paid or (B)&nbsp;that such objectives were partially achieved and that the applicable
bonuses will therefore be awarded in amounts determined in its, his or her sole discretion.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif; margin-left: .25in; width: 7.20in">

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">The Committee may award bonuses to employees based on the foregoing determinations or, after
considering market conditions, the financial position of the Company and other factors, the
Committee may, in its sole discretion, determine not to award any bonuses or to award bonuses at
less than maximum eligibility. All awards under this Program are made at the sole discretion of
the Committee. Notwithstanding any other provision in this Program or in any other communication
made to any employee, no employee shall be entitled to a bonus award under this Program (i)&nbsp;unless
and until a final award has been approved by the Committee, or in the case of a non-executive
employee, the Committee has approved an awards pool to be administered by the CEO and the CEO has
made such final award, and (ii)&nbsp;unless the employee remains an employee of the Company or a
subsidiary of the Company on the date that the award is to be paid. Any award to a person that
commenced employment during the fiscal year will be pro rated based on the portion of the year
during which such person was employed.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>V. </B><U><B>MISCELLANEOUS</B></U>
</DIV>


<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">A.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">This Program is effective beginning with the Company&#146;s 2009 fiscal year and will
continue until the Committee terminates this Program.</DIV></TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">B.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">Nothing contained in this document shall be deemed to alter the relationship between
the Company or any subsidiary of the Company and an employee. Furthermore, nothing
contained in this document shall be construed to constitute a contract of employment
between the Company or any subsidiary of the Company and an employee. Subject to any
employment agreement that may exist between them, they continue to have the right to
terminate the employment or service relationship at any time for any reason, except as
provided in a written contract.</DIV></TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">C.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">This Program replaces and supersedes any and all prior agreements, policies, and/or
plans related to bonus compensation.</DIV></TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
